All Stories

  1. Structure-activity relationship studies on Bax activator SMBA1 for the treatment of ER-positive and triple-negative breast cancer
  2. Applications of Bioorthogonal Chemistry in Tumor-Targeted Drug Discovery
  3. Abstract 3: Discovery and optimization of small molecule Bax activators for cancer therapy
  4. Discovery of Novel Macrocyclic Hedgehog Pathway Inhibitors Acting by Suppressing the Gli-Mediated Transcription
  5. Design, Synthesis, and Pharmacological Evaluation of 2-(2,5-Dimethyl-5,6,7,8-tetrahydroquinolin-8-yl)-N-aryl Propanamides as Novel Smoothened (Smo) Antagonists
  6. Novel dihydroisoxazoline-alkyl carbon chain hybrid artemisinin analogues (artemalogs): synthesis and antitumor activities
  7. Novel spirobicyclic artemisinin analogues (artemalogues): Synthesis and antitumor activities
  8. Computational Drug Repositioning for Cancer Therapeutics
  9. Smiles rearrangement for the synthesis of diarylamines
  10. Synthesis and c-Met Kinase Inhibition of 3,5-Disubstituted and 3,5,7-Trisubstituted Quinolines: Identification of 3-(4-Acetylpiperazin-1-yl)-5-(3-nitrobenzylamino)-7- (trifluoromethyl)quinoline as a Novel Anticancer Agent
  11. Expeditious one-pot synthesis of C3-piperazinyl-substituted quinolines: key precursors to potent c-Met inhibitors